Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Francesca Finotello

Showing results (51-60 of 67) with videos related to

Pageof 7
Sort By:
Cell Death and Differentiation|August 28, 2021
Stress-induced inflammation evoked by immunogenic cell death is blunted by the IRE1α kinase inhibitor KIRA6 through HSP60 targetingNicole Rufo, Dimitris Korovesis, Sofie Van Eygen, et al.
Cancer Cell|November 11, 2022
High-resolution single-cell atlas reveals diversity and plasticity of tissue-resident neutrophils in non-small cell lung cancerStefan Salcher, Gregor Sturm, Lena Horvath, et al.
Journal for Immunotherapy of Cancer|February 26, 2022
Tumor-specific T cells support chemokine-driven spatial organization of intratumoral immune microaggregates needed for long survivalZiena Abdulrahman, Saskia J Santegoets, Gregor Sturm, et al.
Journal for Immunotherapy of Cancer|April 17, 2024
Tumor-targeted therapy with BRAF-inhibitor recruits activated dendritic cells to promote tumor immunity in melanomaFlorian Hornsteiner, Janine Vierthaler, Helen Strandt, et al.
Journal for Immunotherapy of Cancer|January 18, 2022
CD161 expression and regulation defines rapidly responding effector CD4+ T cells associated with improved survival in HPV16-associated tumorsChantal L Duurland, Saskia J Santegoets, Ziena Abdulrahman, et al.
Journal for Immunotherapy of Cancer|June 30, 2026
Metabolic inhibition of glutamate-cysteine ligase increases dendritic cell-mediated antitumor immunity in melanomaSophie Marie Dieckmann, Christoph H Tripp, Helen Strandt, et al.
Nature Medicine|May 21, 2024
A spatial architecture-embedding HLA signature to predict clinical response to immunotherapy in renal cell carcinomaLisa Kinget, Stefan Naulaerts, Jannes Govaerts, et al.
Cell Discovery|November 15, 2023
Single cell dynamics of tumor specificity vs bystander activity in CD8<sup>+</sup> T cells define the diverse immune landscapes in colorectal cancerDaniel Morales Borràs, Sara Verbandt, Markus Ausserhofer, et al.
Nature Medicine|July 15, 2024
Author Correction: A spatial architecture-embedding HLA signature to predict clinical response to immunotherapy in renal cell carcinomaLisa Kinget, Stefan Naulaerts, Jannes Govaerts, et al.
Genome Medicine|May 26, 2019
Molecular and pharmacological modulators of the tumor immune contexture revealed by deconvolution of RNA-seq dataFrancesca Finotello, Clemens Mayer, Christina Plattner, et al.
Pageof 7

Showing results (51-60 of 67) with videos related to

Sort By:
Pageof 7
Cell Death and Differentiation|August 28, 2021
Stress-induced inflammation evoked by immunogenic cell death is blunted by the IRE1α kinase inhibitor KIRA6 through HSP60 targetingNicole Rufo, Dimitris Korovesis, Sofie Van Eygen, et al.
Cancer Cell|November 11, 2022
High-resolution single-cell atlas reveals diversity and plasticity of tissue-resident neutrophils in non-small cell lung cancerStefan Salcher, Gregor Sturm, Lena Horvath, et al.
Journal for Immunotherapy of Cancer|February 26, 2022
Tumor-specific T cells support chemokine-driven spatial organization of intratumoral immune microaggregates needed for long survivalZiena Abdulrahman, Saskia J Santegoets, Gregor Sturm, et al.
Journal for Immunotherapy of Cancer|April 17, 2024
Tumor-targeted therapy with BRAF-inhibitor recruits activated dendritic cells to promote tumor immunity in melanomaFlorian Hornsteiner, Janine Vierthaler, Helen Strandt, et al.
Journal for Immunotherapy of Cancer|January 18, 2022
CD161 expression and regulation defines rapidly responding effector CD4+ T cells associated with improved survival in HPV16-associated tumorsChantal L Duurland, Saskia J Santegoets, Ziena Abdulrahman, et al.
Journal for Immunotherapy of Cancer|June 30, 2026
Metabolic inhibition of glutamate-cysteine ligase increases dendritic cell-mediated antitumor immunity in melanomaSophie Marie Dieckmann, Christoph H Tripp, Helen Strandt, et al.
Nature Medicine|May 21, 2024
A spatial architecture-embedding HLA signature to predict clinical response to immunotherapy in renal cell carcinomaLisa Kinget, Stefan Naulaerts, Jannes Govaerts, et al.
Cell Discovery|November 15, 2023
Single cell dynamics of tumor specificity vs bystander activity in CD8<sup>+</sup> T cells define the diverse immune landscapes in colorectal cancerDaniel Morales Borràs, Sara Verbandt, Markus Ausserhofer, et al.
Nature Medicine|July 15, 2024
Author Correction: A spatial architecture-embedding HLA signature to predict clinical response to immunotherapy in renal cell carcinomaLisa Kinget, Stefan Naulaerts, Jannes Govaerts, et al.
Genome Medicine|May 26, 2019
Molecular and pharmacological modulators of the tumor immune contexture revealed by deconvolution of RNA-seq dataFrancesca Finotello, Clemens Mayer, Christina Plattner, et al.
Pageof 7